Finance

Lists
Outlook: 40.0% bullish·0.0% bearish
Go to analysis
M1CK34:BVMF
Mckesson Corp Bdr
73,22 R$
0,00%
(0,00) 1D
9 հոկ, 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for M1CK34...
Open
72,80 R$
High
73,43 R$
Low
72,80 R$
Mkt. cap
109,46 մլրդ
Avg. vol.
296,00
Volume
69,00
52-wk high
81,67 R$
52-wk low
55,63 R$
Shares outstanding
116,59 մլն
No. of employees
42 հզր
Open
72,80 R$
High
73,43 R$
Low
72,80 R$
Mkt. cap
109,46 մլրդ
Avg. vol.
296,00
Volume
69,00
52-wk high
81,67 R$
52-wk low
55,63 R$
Shares outstanding
116,59 մլն
No. of employees
42 հզր
News stories
From web sources and news partners
Profile
McKesson Corporation is an American publicly traded company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceutical products used or consumed in North America and employs over 80,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a component of the S&P 500 and is listed on the New York Stock Exchange, where it is traded under the ticker symbol "MCK". McKesson provides extensive network of infrastructure for the healthcare industry and was an early adopter of technologies, including barcode scanning for distribution, pharmacy robotics, and RFID tags. The company has been named in a federal lawsuit for profiting from the opioid epidemic in the United States. Throughout the COVID-19 pandemic, McKesson was a key vaccine distributor, serving as the US government's centralized distributor for hundreds of millions of COVID-19 vaccine doses and ancillary supply kits for over a billion doses. Wikipedia
About Mckesson Corp Bdr
CEOBrian S. Tyler
Employees42,3 հզր
Founded1835
Headquarters-
SectorHealth care provider
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
103,15 մլրդ
106,16 մլրդ
96,30 մլրդ
105,38 մլրդ
Cost of goods sold
99,61 մլրդ
102,49 մլրդ
92,25 մլրդ
101,70 մլրդ
Cost of revenue
99,61 մլրդ
102,49 մլրդ
92,25 մլրդ
101,70 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,12 մլրդ
2,03 մլրդ
1,92 մլրդ
2,26 մլրդ
Operating expense
2,12 մլրդ
2,03 մլրդ
1,92 մլրդ
2,26 մլրդ
Total operating expenses
101,73 մլրդ
104,52 մլրդ
94,17 մլրդ
103,96 մլրդ
Operating income
1,42 մլրդ
1,64 մլրդ
2,13 մլրդ
1,42 մլրդ
Other non operating income
62,00 մլն
74,00 մլն
-156,00 մլն
66,00 մլն
EBT including unusual items
1,40 մլրդ
1,63 մլրդ
2,12 մլրդ
1,31 մլրդ
EBT excluding unusual items
1,40 մլրդ
1,65 մլրդ
2,10 մլրդ
1,41 մլրդ
Income tax expense
232,00 մլն
380,00 մլն
270,00 մլն
276,00 մլն
Effective tax rate
16,63%
23,31%
12,71%
21,10%
Other operating expenses
-
-
-
-
Net income
1,11 մլրդ
1,19 մլրդ
1,68 մլրդ
614,00 մլն
Net profit margin
1,08%
1,12%
1,75%
0,58%
Earnings per share
9,86
9,34
11,69
9,93
Interest and investment income
-
-
179,00 մլն
-
Interest expense
-74,00 մլն
-63,00 մլն
-61,00 մլն
-77,00 մլն
Net interest expenses
-74,00 մլն
-63,00 մլն
118,00 մլն
-77,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,60 մլրդ
1,83 մլրդ
2,19 մլրդ
1,62 մլրդ
Gain or loss from assets sale
-102,00 մլն
-
-488,00 մլն
-6,00 մլն
AI content may include mistakes. Learn more
Google Apps